{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:22:58Z","timestamp":1783034578101,"version":"3.54.6"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,14]]},"DOI":"10.1093\/eurheartj\/ehx516","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T16:21:58Z","timestamp":1516119718000},"page":"2635-2638","source":"Crossref","is-referenced-by-count":4,"title":["An update on cardiomyopathies: immune-mediated diseases, sarcoidosis, and peripartum and hypertrophic cardiomyopathies during pregnancy"],"prefix":"10.1093","volume":"38","author":[{"given":"Thomas F.","family":"L\u00fcscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key\n\t\t\t\t20180126132644_ehx516-B1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/eurheartj\/ehv522","article-title":"Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers","volume":"37","author":"Claes","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehu435","article-title":"A novel MYH7 mutation in a family with cardiomyopathy presenting with restrictive physiology and varying degrees of left ventricle hypertrophy","volume":"36","author":"Yu","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"key\n\t\t\t\t20180126132644_ehx516-B5","first-page":"423","article-title":"Myocarditis","volume":"361","author":"Szabo","year":"2009  23","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B6","first-page":"1413","article-title":"Transforming growth factor-\u03b2-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis","volume":"38","author":"Blyszczuk","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B7","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehv321","article-title":"The microRNA-221\/-222 cluster balances the antiviral and inflammatory response in viral myocarditis","volume":"36","author":"Corsten","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B8","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1053\/euhj.2000.2339","article-title":"Hypertensive heart disease. A complex syndrome or a hypertensive \u2018cardiomyopathy\u2019?","volume":"21","author":"Lip","year":"2000","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B9","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B10","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/eurheartj\/ehv660","article-title":"Right ventricular mass: a rare presentation of cardiac sarcoidosis","volume":"37","author":"Bertic","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B12","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/eurheartj\/ehv170","article-title":"Diagnostic assessment and follow-up of cardiac sarcoidosis in a patient presenting with ventricular tachycardia","volume":"36","author":"Berger","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/eurheartj\/ehv608","article-title":"Two cases of cardiac sarcoidosis diagnosed based on biopsy results of the gluteus muscle with focal uptake of 18F-fluorodeoxyglucose","volume":"37","author":"Takahashi","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B14","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/eurheartj\/ehu513","article-title":"Isolated cardiac sarcoidosis: critical role of cardiac MRI for diagnosis and management","volume":"36","author":"Ehl","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B15","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/eurheartj\/ehx132","article-title":"Cardiac sarcoidosis presenting as hypertrophic cardiomyopathy","volume":"38","author":"Haley","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/eurheartj\/ehv009","article-title":"Peripartum cardiomyopathy: current management and future perspectives","volume":"36","author":"Hilfiker-Kleiner","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B17","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy","volume":"35","author":"van Spaendonck-Zwarts","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B18","first-page":"349","article-title":"Low STAT3 expression sensitizes to toxic effects of beta-adrenergic receptor stimulation in peripartum cardiomyopathy","volume":"38","author":"Stapel","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B19","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B20","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/eurheartj\/ehx428","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD","volume":"38","author":"Arrigo","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B21","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes","volume":"38","author":"Walsh","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B22","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B23","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/ehx189","article-title":"Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)","volume":"38","author":"Goland","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180126132644_ehx516-B24","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/eurheartj\/ehx304","article-title":"Pregnancy in hypertrophic cardiomyopathy","volume":"38","author":"Owens","year":"2017","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/35\/2635\/19912969\/ehx516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T18:26:51Z","timestamp":1516991211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/38\/35\/2635\/4157487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":24,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2017,9,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx516","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9,14]]},"published":{"date-parts":[[2017,9,14]]}}}